Not applicableStudy completedNCT04476082What this trial is testingNutrition in Gastrointestinal TumorsWho this might be right forPancreatic CancerOesophageal CancerColon Cancer+7 more University Medicine Greifswald 66
Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 520
Testing effectiveness (Phase 2)UnknownNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 44
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Not applicableEnrolling By InvitationNCT05600933What this trial is testingProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentWho this might be right forSolid TumorsHematologic MalignancyGastrointestinal Cancer+5 more National Cancer Institute (NCI) 1,200
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Not applicableStudy completedNCT02948946What this trial is testingClinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine TumorsWho this might be right forGastroenteropancreatic Neuroendocrine TumorLung Neuroendocrine Neoplasm H. Lee Moffitt Cancer Center and Research Institute 105
Not applicableLooking for participantsNCT06028724What this trial is testingA Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)Who this might be right forSolid TumorAdvanced Solid TumorLocally Advanced Solid Tumor+11 more Centro di Riferimento Oncologico - Aviano 782
Not applicableEnded earlyNCT03073473What this trial is testingEvaluation of the NantHealth GPS Cancer Test in Patients With Advanced CancersWho this might be right forPancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more Cota Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05259696What this trial is testingGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)Who this might be right forOncologyMelanomaOvarian Cancer+14 more Palleon Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Looking for participantsNCT07023731What this trial is testingEvaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationWho this might be right forKRAS G12D MutationAdvanced Solid Cancer Arvinas Inc. 159
Not applicableUnknownNCT00454376What this trial is testingDisease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more National Cancer Institute (NCI) 408
Testing effectiveness (Phase 2)Ended earlyNCT02315625What this trial is testingStudy of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive SurgeryWho this might be right forNeuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more National Cancer Institute (NCI) 16
Early research (Phase 1)Active Not RecruitingNCT04514497What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerWho this might be right forMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Neuroendocrine Carcinoma+9 more National Cancer Institute (NCI) 28
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267What this trial is testingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Who this might be right forBreast CancerCholangiocarcinomaColorectal Cancer+13 more Hoffmann-La Roche 534